The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INVEST: A phase Ib window of opportunity study of atezolizumab administered either intravesically or direct tumour injection in patients with bladder cancer prior to radical cystectomy.
 
Syed A. Hussain
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche
 
Jamie B. Oughton
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); SERVIER (Inst)
 
Ruby Smith Whelan
No Relationships to Disclose
 
Angela Green
No Relationships to Disclose
 
Rachel Hubbard
No Relationships to Disclose
 
Steven Kennish
No Relationships to Disclose
 
Ethan Senior
No Relationships to Disclose
 
Jessica Kendall
No Relationships to Disclose
 
Dominic McCready
No Relationships to Disclose
 
Fiona J. Collinson
Speakers' Bureau - Bayer; Bayer; Bayer
Research Funding - Bristol-Myers Squibb; Roche/Genentech (Inst)
 
Jon Griffin
No Relationships to Disclose
 
James W.F. Catto
No Relationships to Disclose